CytoDyn Inc. (CYDY): Total Assets
$13.97M
As of 2026-05-31
+7.4%
3-year compound annual growth
-36.2%
5-year compound annual growth
+0.1%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-05-31 | $13.97M | -22.6% | 2026-08-31, Balance as of period end |
| 2025-05-31 | $18.05M | +62.1% | 2026-08-31, Balance as of period end |
| 2024-05-31 | $11.14M | -1.4% | 2025-07-25, Balance as of period end |
| 2023-05-31 | $11.29M | -61.3% | 2024-08-15, Balance as of period end |
| 2022-05-31 | $29.18M | -77.9% | 2023-09-14, Balance as of period end |
| 2021-05-31 | $132.08M | +161.5% | 2022-08-15, Balance as of period end |
| 2020-05-31 | $50.51M | +142.0% | 2021-07-30, Balance as of period end |
| 2019-05-31 | $20.87M | +326.1% | 2020-08-14, Balance as of period end |
| 2018-05-31 | $4.90M | -39.2% | 2019-08-14, Balance as of period end |
| 2017-05-31 | $8.06M | -41.6% | 2018-07-27, Balance as of period end |
| 2016-05-31 | $13.79M | +194.6% | 2017-07-20, Balance as of period end |
| 2015-05-31 | $4.68M | -44.5% | 2016-07-19, Balance as of period end |
| 2014-05-31 | $8.43M | +102.7% | 2015-07-10, Balance as of period end |
| 2013-05-31 | $4.16M | +288.3% | 2014-07-10, Balance as of period end |
| 2012-05-31 | $1.07M | -46.3% | 2013-08-29, Balance as of period end |
| 2011-05-31 | $1.99M | n/a | 2012-08-22, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| CytoDyn Inc. (CYDY) | 2026-05-31 | $13.97M | -22.6% |
| Actuate Therapeutics, Inc. (ACTU) | 2025-12-31 | $14.04M | +50.6% |
| Exicure, Inc. (XCUR) | 2025-12-31 | $14.04M | -6.7% |
| Chemomab Therapeutics Ltd. (CMMB) | 2025-12-31 | $13.81M | -18.6% |
| Biovie Inc. (BIVI) | 2026-06-30 | $14.25M | -33.9% |
| CalciMedica, Inc. (CALC) | 2025-12-31 | $13.59M | -31.3% |
| Edesa Biotech, Inc. (EDSA) | 2025-09-30 | $13.53M | +254.8% |
| Cellectar Biosciences, Inc. (CLRB) | 2025-12-31 | $14.98M | -41.2% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $12.96M | +254.9% |
Compare CYDY, ACTU, XCUR, CMMB side by side · Screen every company in Pharmaceutical Preparations ↗